Telix Pharmaceuticals (NASDAQ:TLX) Shares Gap Up on Analyst Upgrade

Shares of Telix Pharmaceuticals Limited (NASDAQ:TLX – Get Free Report) gapped up before the market opened on Tuesday after Royal Bank Of Canada upgraded the stock from a hold rating to a moderate buy rating. The stock had previously closed at $11.31, but opened at $11.93. Telix Pharmaceuticals shares last traded at $11.98, with a [...] [Read Full Story on Americanbankingnews →](https://www.americanbankingnews.com/2026/09/24/telix-pharmaceuticals-nasdaqtlx-shares-gap-up-on-analyst-upgrade.html)